Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Recruiting · NCT06747858 · Registry updated 2026-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Phase 2 | 2026-05-08 | NCT06747858 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Arcturus Therapeutics, Inc. | 3 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Children's Hospital of Los Angeles | Los Angeles | United States | 56 |
| Children's National Hospital | Washington D.C. | United States | 100 |
| Cleveland Clinic Foundation | Cleveland | United States | 370 |
| Joe DiMaggio Children's Hospital | Hollywood | United States | 14 |
| Medical University of South Carolina | Charleston | United States | 628 |
| Seattle Children's Hospital | Seattle | United States | 281 |
| The Cystic Fibrosis Institute | Northfield | United States | 2 |
| University of Arizona | Tucson | United States | 53 |
| University of Arkansas for Medical Sciences | Little Rock | United States | 218 |
| UT Health San Antonio | San Antonio | United States | 29 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |
| Washington University School of Medicine | St Louis | United States | 1 |